What is there to explain? On a peer comparison basis (AKE), the estimate is US$246m. On a broker research basis (Cannacord), it's $284m. That's neatly in line with the CAPEX figure that I estimated (US$250-300m).
You're also forgetting that the 2 ktpa plant cost at least US$36m (on Gcar's calcs, I have it at ~US$40-44m), and that didn't include the ponds which were built five years ago. Global inflation has been rampant since the initial costings, and we can see this with RIO's 50% CAPEX blowout.
Bottom line, there's heaps of evidence to indicate that CAPEX will be in the US$250-300m range. You just don't want to hear it. Never mind, we'll revisit this once the update feasibility study is released. If you're right, I'll be sure to concede. If I'm right, try to show some humility and do the same.
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-18274
-
- There are more pages in this discussion • 5,212 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
-0.002(4.88%) |
Mkt cap ! $56.78M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $29.56K | 758.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 607386 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 260442 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 640526 | 0.039 |
6 | 345700 | 0.038 |
7 | 834127 | 0.037 |
9 | 1147352 | 0.036 |
28 | 3549934 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 260442 | 28 |
0.041 | 678232 | 5 |
0.042 | 242305 | 5 |
0.043 | 335646 | 5 |
0.044 | 1686077 | 7 |
Last trade - 14.03pm 13/08/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online